Cargando…
The impact of Measles-Rubella vaccination on the morbidity and mortality from Congenital Rubella Syndrome in 92 countries
Since 2011, GAVI, The Vaccine Alliance, has funded eligible countries to introduce rubella-containing vaccination (RCV) into their national schedule. Two key indicators used to monitor the impact – the future deaths and DALYs (Disability Adjusted Life Years) averted through vaccination conducted in...
Autores principales: | Vynnycky, Emilia, Papadopoulos, Timoleon, Angelis, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422479/ https://www.ncbi.nlm.nih.gov/pubmed/30285537 http://dx.doi.org/10.1080/21645515.2018.1532257 |
Ejemplares similares
-
Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019
por: Vynnycky, Emilia, et al.
Publicado: (2023) -
Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023) -
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study
por: Winter, Amy K, et al.
Publicado: (2022) -
Immunolocalization and Distribution of Rubella Antigen in Fatal Congenital Rubella Syndrome
por: Lazar, Mihaela, et al.
Publicado: (2015) -
Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
por: Wang, Zhifang, et al.
Publicado: (2014)